Skip to main content

Spencer J. Johnson

ID:LEX-AR-23BYJGH0

/

Claimed Record

/

Organization: Rothwell Figg

Presence of Harm Central to Real Party-in-Interest Issues in PTAB Precedential Decisions

PTAB Law Blog · April 23, 2019

Claims of Genentech’s Carter ’213 Patent Found Unpatentable

Biosimilars Law Bulletin · December 11, 2018

Federal Circuit Confirms that New Evidence Before PTAB Sinks Claims that Survived ITC Action

PTAB Law Blog · October 3, 2018

First IPR Against Biogen’s ’172 Patent Instituted After Multiple Attempts

Biosimilars Law Bulletin · July 24, 2018

Litigation Spotlight Update: Epogen® Litigation Status in Face of Retacrit Regulatory Approval

Biosimilars Law Bulletin · May 22, 2018

Practice Areas

Health Care and Life Sciences

Intellectual Property

Jurisdictions

Washington, D.C.